Nanoscope Therapeutics has received Pioneering Regenerative Medical Product (Sakigake) and Orphan Drug designations for ...
Nanoscope has received a new patent ( US Patent No. 12459977) from the US Patent and Trademark Office (USPTO) for the company’s Multi-Characteristic Opsin (MCO) technology platform as a novel and ...
DALLAS, Jan. 7, 2026 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor ...
A new brain device from Northwestern University is asking a daring question: what if information could reach your brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback